Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Brands Regains New Momentum: As QDegrees Bolsters Customer Experience for Business Growth Business
  • XXVI Convocation of FORE School of Management, New Delhi Business
  • The Moon Store Welcomes the Summer with Mango and Strawberry Freeze-dried Fruit Flavors Business
  • Successful Beach Clean-Up Drive at Juhu Beach Organized by PS Foundation Lifestyle
  • Sarvodaya Hospital, Faridabad, brings North India’s First Hip Navigation Technology for Hip Replacement Surgeries Health
  • How Hyperlocal Digital Platforms Can Transform Small Businesses in India Business
  • Large Sender has helped brands Bocoran Bola Info Gacor Geetha Pi FAIR2DEAL Shabby Online KASVI Bid Exchange D247 Technology
  • SEPC Secured INR 269.68 Crore Sub-Contract for Strategic Ajmer-Chanderiya Railway Doubling Project Business

Lincoln Pharmaceuticals Ltd enters elite league; Enters Rs. 1,000 crore plus market cap club

Posted on August 30, 2023 By

Company has set a target of achieving Rs. 750 crore revenue by FY26

Ahmedabad (Gujarat) [India], August 30: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has entered the elite league and Rs. 1,000 crore plus market capitalization companies club for the first time. Share price of the company hit a 52 week high of Rs. 513 per share on 28 August 2023 – gain of over 75% in a year’s time. Company aims to maintain healthy growth in revenue and margins in the coming years and has set a target of achieving Rs. 750 crore revenue by FY26 while maintaining its ‘Net Debt Free’ status.

For FY23, the company has reported its Best-ever results in a financial year with highest – Revenue, EBITDA and Net Profit. Company achieved a milestone of Rs. 500 crore plus revenue and Rs. 100 crore plus profit before tax for the first time in a financial year. During Q1FY24 also, company reported an excellent operational and financial performance with Y-o-Y growth of 26.7% in Net Profit, 21.4% growth in EBITDA and 10.3% growth in Total Income.

Company has successfully completed expansion of the Cephalosporin plant at Mehsana, Gujarat. Commercial production from this plant has started and the company started selling in the domestic markets with product registration under process for many countries for exports. The plant is expected to contribute sales of around Rs. 150 crore in next 3 years.

Company is also ranked among a very few companies to achieve a profit growth every single year from FY13 to FY23. It is among only 16 companies out of 4,200 plus listed companies in the Indian stock exchange to do so as per the analysis of Morningstar. During 10 years from FY13 to FY23, Company has delivered a robust CAGR of over 22% in Net profits, 19% plus in EBITDA and over 10% in Revenue.

Financial Performance – Lincoln Pharmaceuticals FY 13 to FY23

Rating agencies, CRISIL has upgraded its ratings on the company’s bank facilities to ‘CRISIL A/Stable and CRISIL A1’. ICRA too has reaffirmed the company’s long-term and short-term bank facilities to A and A1 respectively. The liquidity position of the company is on a strong foundation, supported by healthy cash accruals, no-term debt, and healthy return ratios.

Over the last few years, promoter group have gradually increased their stake in the company. Foreign institutional investors holding as on June 2023 stands at 1.74%. In the last one year, share price of the company has gained by over 75% – from Rs. 283.5 per share on 29 August 2022 to Rs. 4505 per share at close on 28 August 2023.

Company currently exports to 60 plus countries including East & West Africa, Central, North & Latin America and Southeast Asia. Company has recently started exports to Canada. TGA – Australia and EU GMP approvals will further strengthen the company’s presence and expand its network to 90 plus countries.

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, TGA, WHO-GMP; ISO-9001:2015, ISO-14001:2015 and ISO-45001:2018. Company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, ant-diabetic, anti-malaria among others. Company has filed 25 plus patent applications and is awarded with seven patents.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: Funding Guru Subodh Bajpai Launches his Book Rise and Thrive Unleashing The Entrepreneurial Warrior”
Next Post: CSR Times and Indian Achievers’ Forum host the National Seminar on “Achieving SDG’s through CSR in developing Economies: Role of G20 Nations”

Related Posts

  • “MY SAMPPATI- Ab Aapka Ghar Hamari Zimmedari” by Kappil Jhaverri & Atrri Mukherjjee unveils a new era in real estate Business
  • Booster Water launches a range of Alkaline Ionised water Business
  • Business Mint Triumphantly Unveils Winners of the Fourth Edition Nationwide Awards Under 30 Entrepreneurs and Industry Experts – 2024 Business
  • Iconic Gold Awards 2023 Set to Recognize Outstanding Performers of Bollywood and Television Industry Business
  • Sanjeevana Institute – Helping graduates get market-ready Business
  • AQT Direct Limited Expands Footprint with Grand Opening of Third Office in Gurugram Business

Recent Posts

  • PPFAS Asset Management appoints Devendra Ghalsashi as Chief Operating Officer
  • Irfan Pathan and Adah Sharma Grace the Launch of Youth Cricket League’s YCLT10
  • From Military Service to Social Change: Ramesh Sangle Explores Nation-Building in BRIGADE
  • Samiran Tea Unveils New Product Portfolio, Including 10 Herbal Tea Blends, at Noida Office Inauguration
  • Manav’s ‘Bardic Voices: Where the Horizon Meets, the Magic Begins’ Explores Memory, Humanity, and the Search for Meaning

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Parents’ Health Conditions – Responsible For ASD? Health
  • Perpetuuiti bags Critical Enterprise Automation Project for Saudi Telecom Company Business
  • Raychem RPG achieves significant milestone to facilitate faster execution in electricity distribution projects with its ‘Make India’ initiative Business
  • Maharashtra Visionary Summit 2025: Celebrating Leadership, Innovation & the State’s Vision for Nation-Building National
  • Global Icon Awards 2025 Business
  • Mr. Abhay Tewari appointed Managing Director and Chief Executive Officer of SUD Life A
  • Virtuoso Optoelectronics Moves to the NSE and BSE Main Boards, Strengthening Its Growth Journey Business
  • Introducing the All New AI Direct Drive™ Washing Machine by LG: Revolutionizing Laundry Care Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme